Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience (Q37701881)

From Wikidata
Jump to navigation Jump to search
scientific article published on 02 August 2013
edit
Language Label Description Also known as
English
Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience
scientific article published on 02 August 2013

    Statements

    Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience (English)
    Jason J Luke
    Margaret K Callahan
    Emanuela Romano
    Mark Bluth
    Donald P Lawrence
    Patrick A Ott
    Ryan J Sullivan
    James J Harding
    Mark Dickson
    Gary K Schwartz
    Paul B Chapman
    Richard D Carvajal
    2 August 2013
    119
    3687-3695

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit